Physician profile
Justin E Morgan
NPI 1720077761
$6,172.66
in general payments reported to CMS, 2019-2025
24 companies · $874 in 2025
The $874 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $820 · 2020: $918 · 2021: $1,328 · 2022: $606 · 2023: $622 · 2024: $1,005 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,467 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,466.66 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,203.21 | 2021-2025 | Inspire |
| Stryker Corporation | $1,022.47 | 2019-2025 | Scopis Ent, Xpress Ent Dilation System |
| Regeneron Healthcare Solutions, INC. | $582.52 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $489.24 | 2019-2025 | Nucala |
| Genzyme Corporation | $417.76 | 2019-2025 | |
| Aerin Medical INC. | $335.56 | 2019-2024 | |
| Genentech USA, INC. | $328.09 | 2019-2024 | Xolair |
| Novartis Pharmaceuticals Corporation | $302.37 | 2019-2025 | |
| Kaleo, INC. | $204.37 | 2019-2024 | Auvi-Q |
| Optinose US, INC. | $203.69 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $178.37 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Acclarent, INC | $169.11 | 2021-2024 | Acclarent Navwire, Acclarent Aera, Trudi Nav Cable |
| Smith+Nephew, INC. | $154.72 | 2020-2024 | Halo |
| Alk-Abello, INC | $151.63 | 2019-2022 | |
| Xoran Technologies LLC | $107.15 | 2023 | Minicat |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $73.01 | 2019-2021 | |
| Ars Pharmaceuticals Operations, INC. | $69.19 | 2025 | Neffy |
| Medtronic, INC. | $44.15 | 2021-2024 | Propel |
| Amgen INC. | $34.00 | 2025 | |
| Arbor Pharmaceuticals, INC. | $26.05 | 2019 | |
| Hologic Sales and Service, LLC | $21.40 | 2023 | Coolseal Generator |
| Phadia US INC. | $20.11 | 2024 | Immunocap |
| Integra Lifesciences Corporation | $18.27 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Olympus America INC. | $16.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.